Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 8098203)

1.

Time course and biologic correlates of treatment response in first-episode schizophrenia.

Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M.

Arch Gen Psychiatry. 1993 May;50(5):369-76.

PMID:
8098203
2.

Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates.

Lieberman JA, Jody D, Alvir JM, Ashtari M, Levy DL, Bogerts B, Degreef G, Mayerhoff DI, Cooper T.

Arch Gen Psychiatry. 1993 May;50(5):357-68.

PMID:
8489325
3.

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA.

Am J Psychiatry. 1999 Apr;156(4):544-9.

PMID:
10200732
4.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
5.

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.

Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, et al.

Am J Psychiatry. 1995 May;152(5):698-703.

PMID:
7726309
6.

Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital.

Lieberman JA, Alvir JM, Woerner M, Degreef G, Bilder RM, Ashtari M, Bogerts B, Mayerhoff DI, Geisler SH, Loebel A, et al.

Schizophr Bull. 1992;18(3):351-71.

7.

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi D, Fenzi M, Chiavacci MC, Bottai M, Ramacciotti CE, Cassano GB.

J Clin Psychiatry. 2003 Apr;64(4):451-8.

PMID:
12716249
8.

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

Chakos MH, Alvir JM, Woerner MG, Koreen A, Geisler S, Mayerhoff D, Sobel S, Kane JM, Borenstein M, Lieberman JA.

Arch Gen Psychiatry. 1996 Apr;53(4):313-9.

PMID:
8634009
9.

Duration of psychosis and outcome in first-episode schizophrenia.

Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR.

Am J Psychiatry. 1992 Sep;149(9):1183-8.

PMID:
1503130
10.

Time course for antipsychotic treatment response in first-episode schizophrenia.

Emsley R, Rabinowitz J, Medori R.

Am J Psychiatry. 2006 Apr;163(4):743-5.

PMID:
16585455
11.

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.

Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG; Risperidone Long-Acting Trial Investigators (R-LAI).

Hum Psychopharmacol. 2009 Oct;24(7):574-83. doi: 10.1002/hup.1067.

PMID:
19790173
12.

Antipsychotic drug effects on brain morphology in first-episode psychosis.

Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group.

Arch Gen Psychiatry. 2005 Apr;62(4):361-70.

PMID:
15809403
13.

Course of treatment response in first-episode and chronic schizophrenia.

Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE.

Am J Psychiatry. 1996 Apr;153(4):519-25.

PMID:
8599400
14.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
15.

Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.

Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T.

Arch Gen Psychiatry. 1994 Feb;51(2):132-8.

PMID:
7905259
16.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
17.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
18.

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M.

Am J Psychiatry. 1994 Oct;151(10):1430-6.

PMID:
7916539
19.

Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.

Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Kahn R, Gur R, Tollefson G; HGDH Research Group.

Br J Psychiatry. 2004 Jul;185:18-24.

20.

Olanzapine versus haloperidol treatment in first-episode psychosis.

Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C Jr, Tollefson GD.

Am J Psychiatry. 1999 Jan;156(1):79-87.

PMID:
9892301
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk